Cell Impact (Sweden) Today

CI Stock   0.18  0.01  5.88%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 64

 
High
 
Low
Quite High
Cell Impact is selling for under 0.18 as of the 24th of November 2024; that is 5.88 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.17. Cell Impact has more than 64 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Cell Impact AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of September 2024 and ending today, the 24th of November 2024. Click here to learn more.

Moving together with Cell Stock

  0.79AZN AstraZeneca PLCPairCorr

Moving against Cell Stock

  0.53NDA-SE Nordea Bank AbpPairCorr
  0.45ALIV-SDB AutolivPairCorr
  0.38VOLV-B AB VolvoPairCorr
  0.32VOLV-A AB VolvoPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Cell Impact AB Risk Profiles

Although Cell Impact's alpha and beta are two of the key measurements used to evaluate Cell Impact's performance over the market, the standard measures of volatility play an important role as well.

Cell Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cell Impact without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run AI Portfolio Architect Now

   

AI Portfolio Architect

Use AI to generate optimal portfolios and find profitable investment opportunities
All  Next Launch Module

Cell Impact Corporate Management

Elected by the shareholders, the Cell Impact's board of directors comprises two types of representatives: Cell Impact inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cell. The board's role is to monitor Cell Impact's management team and ensure that shareholders' interests are well served. Cell Impact's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cell Impact's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tord LattChief OfficerProfile
Stefan AxellieChief OfficerProfile
Daniel VallinChief OfficerProfile
Shigeru NakagawaManaging IncProfile
Pr TeikeChief OfficerProfile
Karina LarssonChief OfficerProfile
Anders bergChief OfficerProfile

Additional Tools for Cell Stock Analysis

When running Cell Impact's price analysis, check to measure Cell Impact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Impact is operating at the current time. Most of Cell Impact's value examination focuses on studying past and present price action to predict the probability of Cell Impact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Impact's price. Additionally, you may evaluate how the addition of Cell Impact to your portfolios can decrease your overall portfolio volatility.